This is just gruesome.
A skincare company has started using aborted fetal tissue in its anti-aging skincare cream.
Christian News Wire reported:
Children of God for Life announced today that Neocutis, a bio-pharmaceutical company focused on dermatology and skin care is using aborted fetal cell lines to produce several of their anti-aging skin creams.
“It is absolutely deplorable that Neocutis would resort to exploiting the remains of a deliberately slaughtered baby for nothing other than pure vanity and financial gain,” stated Executive Director Debi Vinnedge. “There is simply no moral justification for this.”
For years Children of God for Life has been a watchdog on pharmaceutical companies using aborted fetal cell lines in medical products and they have received thousands of inquiries from the public on the use of aborted fetal material in cosmetics.
Until now, this was the first time they have encountered any company bold enough to put the information right on their own website and product literature. A quick investigation into the science behind the products revealed the shameless data.
Neocutis’ key ingredient known as “Processed Skin Proteins” was developed at the University of Luasanne from the skin tissue of a 14-week gestation electively-aborted male baby donated by the University Hospital in Switzerland. Subsequently, a working cell bank was established, containing several billion cultured skin cells to produce the human growth factor needed to restore aging skin. The list of products using the cell line include: Bio-Gel, Journee, Bio-Serum, Prevedem, Bio Restorative Skin Cream and Lumiere. But Vinnedge is calling for a full boycott of all Neocutis products, regardless of their source.
“There is absolutely no reason to use aborted babies for such selfish motives,” Vinnedge said. “It is anti-life, anti-woman and counter-productive as Neocutis is about to find out!”
Neocutis describes their Processed Skin Cell Proteins (PCP) used in their anti-aging creams on their website:
From the website:
Through years of research, physicians discovered fetal skin has a unique ability to heal wounds without scarring. Inspired by this, medical researchers at the University Hospital of Lausanne, Switzerland created a biotechnology process to extract the rich proteins responsible for scarless wound healing from cultured fetal skin cells. A small biopsy of fetal skin was donated following a one-time medical termination and a dedicated cell bank was established for developing new skin treatments.